Примери за използване на Committee therefore на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
The Committee therefore recommended that Cancidas be given marketing authorisation.
Such‘monitoring' would violate the principle of separation of powers; the Committee therefore calls for an independent‘advisory body' or a‘helpdesk' to be set up to support initiators when preparing and launching a European Citizens' Initiative so that obvious conflicts with the rules on admissibility and implementation can be avoided in most cases, even if they cannot be ruled out altogether.
The Committee therefore sees no reason to incorporate bans or obstacles.
The Committee therefore finds that the author's rights under article 19, paragraph 2, of the Covenant have been violated.”.
The Committee therefore proposes practical solutions to try to overcome the existing issues in the future.
The Committee therefore recommended that marketing of modified-release paracetamol medicines should be suspended.
The Committee therefore considers the one-year time limit proposed by the Commission to be too short, and would recommend 18 months.
The Committee therefore considered that Spedra's benefits are greater than its risks and recommended that it be approved for use in the EU.
The Committee therefore concluded that the benefits of Trajenta outweigh its risks and recommended that it be granted marketing authorisation.
The Committee therefore concluded that the medicine's benefits are greater than its risk and recommended that it be approved for use in the EU.
The Committee therefore decided that the benefits of Colobreathe are greater than its risks and recommended that it be given marketing authorisation.
The Committee therefore strongly encourages the EU to develop the Marine Observation and Data Network into a worldwide marine data network.
The Committee therefore recommended that the marketing authorisation granted in Finland should not be recognised in other Member States of the EU.
The Committee therefore decided that the benefits of Kentera gel also outweighed its risks and recommended the approval of the new formulation.
The Committee therefore concluded that the benefits of Daklinza outweigh its risks and recommended that it be approved for use in the EU.
The Committee therefore hopes that the limitations entailed by the transitional periods affecting nationals of the new Member States will soon be abolished.
The Committee therefore concluded that biowaver was justified and the risk-benefit balance for Okrido in the applied indications is favourable.
The Committee therefore proposes the creation of a crisis reserve for situations when a new task or an unforeseen crisis comes up, and a non-programmed reserve.
The Committee therefore recommended that the product information should be updated to reflect this risk and include a warning on the signs of hypersensitivity.
The Committee therefore welcomes the aim of aligning EU regulatory norms with the agreements signed with Canada in the following areas.
The Committee therefore underlines in this regard the importance of pilot projects which can develop and showcase European capabilities, technology and commitment to peace.
The Committee therefore concluded that the benefits of Seasonique outweigh its risks and recommended that marketing authorisation be granted in the reference and concerned Member States.
The Committee therefore calculated minimum time spans that should elapse between administration of these substances and calving or lambing/kidding for each substance, species and route of administration.
The Committee therefore calculated a minimum time spans of 2 months for cattle and reindeer and 70 days for sheep that should elapse between administration of these doramectin containing products and calving or lambing.
The Committee therefore calls for swift action in order to achieve a successful outcome, particularly as it fits into a broader framework that is of particular interest to the Committee; .
The Committee therefore calls on European policy makers to embed social dialogue and participation in the structure of the various policy processes that form part of the Europe 2020 process.
The Committee therefore concluded that, based on currently available information, the benefit-risk balance of pholcodine-containing products in the treatment of non-productive cough is positive under normal conditions of use.
The Committee therefore welcomes the announcement that an EU social dialogue committee was set up on 19 June 2013 in which the social partners will, in full autonomy, discuss working conditions, among other things.
The Committee therefore considered that, in the context of Article 8(3) of Regulation(EC) No 141/2000, clinical superiority of Tobramycin VVB over TOBI Podhaler in a substantial portion of the target population can be established.
The Committee therefore recommends drafting accompanying guidelines for both Member States and host enterprises/organisations on possible ways to support training schemes via European and national funding sources already available.